DR.Chip Biotechnology Incorporation announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was TWD 93.345 million compared to TWD 104.489 million a year ago. Operating loss was TWD 33.426 million compared to TWD 19.207 million a year ago. Net loss was TWD 27.096 million compared to TWD 11.865 million a year ago. Basic loss per share from continuing operations was TWD 0.56 compared to TWD 0.25 a year ago.